Ongoing risk stratification for differentiated thyroid cancer (DTC)—stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of …
J Krajewska, M Jarząb, A Czarniecka… - Endokrynologia …, 2016 - journals.viamedica.pl
Introduction: Adequate postoperative risk assessment currently constitutes the principle of
DTC treatment and further management. The aim of the study—a retrospective assessment …
DTC treatment and further management. The aim of the study—a retrospective assessment …
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
KM Van Tol, PL Jager, EG De Vries… - European journal of …, 2003 - academic.oup.com
Background Management of patients with differentiated thyroid carcinoma with negative
diagnostic radioiodide scanning and increased serum thyroglobulin (Tg) concentrations is a …
diagnostic radioiodide scanning and increased serum thyroglobulin (Tg) concentrations is a …
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients
FA Verburg, U Mäder, C Reiners… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
L Lorusso, E Minaldi, G Esposito, P Piaggi… - Journal of …, 2023 - Springer
Objective To report the experience of a single center for the selection of radioiodine-
refractory (RAIR) thyroid cancer patients (RAIR-TC) who needed tyrosine kinase inhibitor …
refractory (RAIR) thyroid cancer patients (RAIR-TC) who needed tyrosine kinase inhibitor …
Can the American thyroid association risk of recurrence predict radioiodine refractory disease in differentiated thyroid cancer
A Hassan, S Riaz, H Bashir, MK Nawaz… - European Thyroid …, 2016 - etj.bioscientifica.com
Objective: The aim of this study was to compare the TNM staging system and the American
Thyroid Association (ATA) recurrence risk classification in predicting radioiodine refractory …
Thyroid Association (ATA) recurrence risk classification in predicting radioiodine refractory …
Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score–matched analysis
H Guo, N Zhang, Y Hu, F Zhang, T Huang… - Frontiers in …, 2023 - frontiersin.org
Background The management guidelines of radioactive Iodine (RAI) therapy for distinct
types of differentiated thyroid carcinoma (DTC) were the same in clinical practice. However …
types of differentiated thyroid carcinoma (DTC) were the same in clinical practice. However …
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients
A Campennì, RM Ruggeri, M Siracusa… - European Journal of …, 2021 - Springer
Aim Total thyroidectomy and risk-adapted 131-radioiodine therapy (RaIT) are the treatments
of choice in differentiated thyroid cancer (DTC) patients. The response to treatments is …
of choice in differentiated thyroid cancer (DTC) patients. The response to treatments is …
99mTc-pertechnetate scintigraphy predicts successful postoperative ablation in differentiated thyroid carcinoma patients treated with low radioiodine activities
L Giovanella, G Paone, T Ruberto… - Endocrinology and …, 2019 - synapse.koreamed.org
Background Postoperative routine radioiodine (RAI) treatment is currently debated for
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low …
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low …
Low activity versus high activity: noninferior response to radioiodine therapy in differentiated patients with extrathyroid extension
C Wang, T Zhao, H Li, W Gao, Y Lin - Nuclear Medicine …, 2017 - journals.lww.com
Objectives Radioactive iodine (RAI) therapy is recommended for differentiated thyroid
cancer (DTC) patients with microscopic extrathyroid extension (ETE). Patients with a low …
cancer (DTC) patients with microscopic extrathyroid extension (ETE). Patients with a low …
Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
AS Alzahrani, G Mohamed, A Al Shammary… - Journal of …, 2005 - Springer
Following the initial management, some patients with differentiated thyroid cancer (DTC)
develop a state of high thyroglobulin (Tg) and negative diagnostic radioactive iodine (RAI) …
develop a state of high thyroglobulin (Tg) and negative diagnostic radioactive iodine (RAI) …